NCT06889012

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 4-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1018" and Coadministration of "BR1018A" and "BR1018B" in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Boryung Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The purpose of this clinical study is to evaluate the pharmacokinetics and the safety after administration of BR1018 and coadministration of BR1018A and BR1018B in healthy volunteers

Conditions

• Essential Hypertension
• Primary Hypercholesterolemia

Interventions

Type	Name	Description
DRUG	BR1018	One tablet administered alone
DRUG	BR1018A	One tablet administered alone
DRUG	BR1018B	One tablet administered alone

Timeline

• Start date: 2025-05-07
• Primary completion: 2025-07-23
• Completion: 2025-07-23
• First posted: 2025-03-21
• Last updated: 2025-09-12

Locations

1 site across 1 country: South Korea